Skip to main content
DNA Labs India

DYSF Gene Limb-girdle muscular dystrophy, autosomal recessive type 2B NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

DYSF Gene Limb-girdle muscular dystrophy, autosomal recessive type 2B NGS Genetic Test

Short Name: DYSF LGMD2B NGS Test

Also known as: LGMD2B Genetic Test, DYSF Gene Mutation Analysis, Dysferlinopathy NGS Test

DYSF Gene Limb-girdle muscular dystrophy, autosomal recessive type 2B NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically delivered within 3 to 4 weeks after the sample is received by the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To confirm the clinical diagnosis of limb-girdle muscular dystrophy type 2B (LGMD2B) by identifying pathogenic variants in the DYSF gene using NGS technology. It also helps in carrier detection and genetic counselling of at-risk family members when a familial mutation is known.

Test Code
4200
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are typically delivered within 3 to 4 weeks after the sample is received by the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. A valid consent is necessary. A genetic counselling session will be conducted to draw a pedigree chart of family members affected with the disease.

Method: Peripheral blood draw / FTA card spot

Step 2

Laboratory Analysis

Blood sample is drawn by a trained phlebotomist. For FTA card sample, a drop of blood is placed on the card and allowed to dry.

Step 3

Report Delivery

The sample should be transported to the laboratory as per instructions. Whole blood samples must not be frozen and should be kept at ambient temperature.

Timeline: Reports are typically delivered within 3 to 4 weeks after the sample is received by the laboratory.

Patient Instructions

1
Before the Test:No special preparation is needed. A genetic counselling session may be scheduled to obtain a detailed family history and to obtain informed consent.
2
During the Test:A blood sample or dried blood spot will be collected. The procedure is quick and minimally invasive.
3
After the Test:You may resume normal activities. The laboratory will process the sample for NGS analysis, and reports will be shared within 3 to 4 weeks.

About This Test

Who Should Get This Test

To confirm the clinical diagnosis of limb-girdle muscular dystrophy type 2B (LGMD2B) by identifying pathogenic variants in the DYSF gene using NGS technology. It also helps in carrier detection and genetic counselling of at-risk family members when a familial mutation is known.

How to Prepare

  • Ensure the sample tube is properly labeled with patient name and ID
  • Use an EDTA vacuum tube for whole blood collection
  • For FTA card, fill the marked circles completely with blood
  • Do not refrigerate FTA card samples; keep them dry at room temperature

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic confirmation of LGMD2B guides management and counselling. This NGS test offers a reliable, single-step approach for DYSF mutation detection."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
ContainerEDTA tube / FTA card
Collection MethodPeripheral blood draw / FTA card spot

Sample Stability

Whole blood in EDTA: stable for 24-48 hours at ambient temperature
Extracted DNA: stable for months when stored at -20°C or below
FTA card blood spot: stable for several weeks at room temperature
Sample Rejection Criteria:
  • Hemolyzed or clotted blood samples
  • Improperly labeled specimens
  • Insufficient blood volume or inadequate sample for DNA extraction
  • Samples exposed to extreme heat or repeated freezing-thawing

Understanding Your Results

The result of the DYSF gene NGS test is evaluated by a clinical geneticist in the context of the patient's clinical presentation, muscle biopsy findings (if any), family history and other laboratory results.
📊

Positive - Pathogenic or likely pathogenic variant identified

Confirms the diagnosis of LGMD2B. Genetic counseling is recommended for the patient and family members.

Action: Discuss with a neurologist and genetic counselor for management and family planning.

📊

Negative - No pathogenic/likely pathogenic variant identified

Does not exclude LGMD2B if clinical suspicion is strong; other genetic or acquired causes should be considered.

Action: Consider further testing such as a comprehensive LGMD panel or muscle biopsy.

📊

Variant of Uncertain Significance (VUS)

A change in the DYSF gene was detected but its clinical significance is not yet established.

Action: Follow-up familial segregation studies and functional studies may be required to clarify the variant's role.

⚠️ When to Consult a Doctor:

If the test result is positive for a pathogenic DYSF mutation, consult a neurologist and clinical geneticist to discuss treatment, rehabilitation and reproductive options. Also, if you experience unexplained muscle weakness and your doctor suspects LGMD, ask about this test.

Limitations

  • NGS may not detect large exon dosage alterations, deep intronic variants, or certain repeat expansions that could cause LGMD2B
  • Results may include variants of uncertain significance (VUS) which require further evaluation
  • This test does not rule out other types of LGMD caused by genes other than DYSF

Risks & Considerations

  • No significant physical risks are associated with blood collection apart from minor bruising or discomfort at the puncture site.
  • Possible psychological stress from receiving a genetic diagnosis.
  • Risk of incidental findings unrelated to the clinical question.

Interfering Factors

  • Poor DNA quality or quantity
  • Contamination during sample collection or processing
  • Presence of maternal cell contamination in prenatal samples (not applicable for postnatal blood/FTA samples)

Frequently Asked Questions

What is the DYSF gene and how is it related to LGMD2B?
The DYSF gene provides instructions for making dysferlin, a protein involved in muscle cell repair. Mutations in DYSF cause limb-girdle muscular dystrophy type 2B (LGMD2B), leading to progressive muscle weakness.
Who is a candidate for this NGS genetic test?
Patients with clinical features suggestive of LGMD2B, including difficulty rising from a chair, climbing stairs, or lifting objects, and where the doctor suspects a genetic cause. Family members of confirmed LGMD2B patients may also require testing.
What is the cost of the DYSF gene LGMD2B NGS test in India?
The test is offered at DNA Labs India at a special price of INR 20,000.
What clinical samples are accepted for this test?
Peripheral blood, extracted DNA, or one drop of blood on an FTA card can be used for testing.
Do I need to be fasting before giving a blood sample?
No, fasting is not required for this genetic test.
How long does it take to receive the test report?
The turnaround time is 3 to 4 weeks from the date the sample is received in the laboratory.
Can this test confirm the diagnosis of LGMD2B?
Yes, identifying a pathogenic mutation in the DYSF gene by NGS confirms the diagnosis of LGMD2B in the appropriate clinical context.
Are there any risks or discomfort associated with sample collection?
No serious risks. Only minor bruising or pain at the blood draw site may occur.
Is genetic counseling available before ordering this test?
Yes, a genetic counseling session to draw a pedigree chart of family members is part of the pre-test process.
What does a positive result mean?
A positive result means a disease-causing mutation has been identified in the DYSF gene, confirming the clinical diagnosis of LGMD2B.
What does a negative result mean?
A negative result indicates no pathogenic/likely pathogenic DYSF variant was detected. It does not completely exclude LGMD2B if the clinical suspicion is strong; other muscular dystrophy genes should be considered.
How accurate is NGS technology for detecting DYSF mutations?
NGS is highly accurate in detecting single nucleotide variants, small insertions/deletions and splice-site mutations in the DYSF gene. However, it may not detect large deletions or duplications; additional testing may be needed.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.